StemCells Therapy

EAST SETAUKET,N.Y., May 1, 2012 /PRNewswire/ –John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. (LIXT.PK), announced the submission of an IND application to the Food and Drug Administration to conduct a Phase I trial of its lead, anti-cancer compound, LB-100.

Soybean is a very important crop and researchers have plans for the next hundred years to work on the genetic code of this crop in order to produce better soybean crop. Already this crop has benefited from biotechnology when roundup resistant varieties were introduced in 1996. The first generation of the crop yielded good results [...]

There is some good news for people suffering from obesity. Researchers at the University of California have discovered a small molecule which could play a pivotal role in controlling diabetes which is a slow killer disease and help in development of treatment for adult onset diabetes. Called as Boc5, this molecule leads to stimulation of [...]

Most of the developing economies around the world have better crop productivity but seems to be lacking behind in the productivity of livestock. Livestock has an important part to play in the agriculture sector but most of the developing economies have a poor genetic potentiality of indigenous animals and this is causing a lot of [...]

Brain cancer cells can be killed dramatically by blocking genetic threads in the rich tapestry of cancer-causing biochemical signals with a statin and an experimental anti-tumor drug. Though the pairing of cholesterol-lowering lovastatin and cyclopamine is unlikely, it is found to be able to eventually kill 63 percent of lab-grown medulloblastoma cells, compared to just [...]

Worried about wrinkles on your skin and can’t stand them? You are not the only one facing this problem as millions of women around the world are struggling with it. Now here comes DermaLastyl-B which is being regarded as the first anti aging face cream which can help in addressing the inability of the body [...]

Start having genetically engineered eggs for your breakfast as they can help in offering protection against cancer. The protein in these special eggs can help in creating cancer fighting drugs. The credit for these eggs goes to Roslin Institute which claims that it has developed five generations of eggs containing life saving proteins. Professor Harry [...]

One of the most common diseases affecting the central nervous system is multiple sclerosis. Up till now interferon-beta was found out to be effective in reducing the progress of the disease and the relapse rate. Fraunhofer laboratory’s therapeutic protein has become the first protein to get the approval as a biogeneric medicine. Human protein was [...]

Key points in human genome have been mapped by American researchers successfully and this is expected to aid in the development of treatments for cancer and a host of other diseases. Dana-Farber Cancer Institute doctors have been able to chart positions of nucleosomes throughout the human genome. This piece of information has found a place [...]

A high-profile report released in U.S by Earth Policy Institute had stated that the ethanol industry of U.S might have an adverse impact on grain prices and even cause food riots worldwide but experts from the field of biotechnology have stated that they would never let this happen and fulfill all the requirements for food [...]

Researchers have developed plant seeds proteins which are quite similar to antibodies. These have been created by Ghent University researchers and are expected to emerge as a cheaper alternative to medication produced currently. The researchers showed that the proteins produced from plant seed were as active as the antibodies which are found in the human [...]

WASHINGTON–(BUSINESS WIRE)– The Biotechnology Industry Organization (BIO) thanks members of the Senate Agriculture Committee, in particular Chairwoman Sen. Debbie Stabenow (D-Mich.), Ranking Member Sen. Pat Roberts (R-Kans.), Sen.

WASHINGTON–(BUSINESS WIRE)– Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the Obama Administration’s new National Bioeconomy Blueprint issued today: BIO applauds President Obamas leadership in creating a National Bioeconomy Blueprint and identifying the bioeconomy as a priority for his Administration. We appreciate the Presidents recognition of the need to clear the path for American innovation and ingenuity and unleash the tremendous promise of biotechnology to help solve many of the biggest challenges facing our nation today and foster economic growth throughout the United States. Already, biotechnology is enabling patients living with debilitating diseases such as cancer, diabetes and Parkinsons – and all American families – to have a higher quality of life, in a healthy and safe environment

Biotechnology Industry Organization: WHAT: WHO: H. Thomas Watkins, President and CEO, Human Genome Sciences The Hon

Facts about CU’s new biotechnology building 975,000 bricks were used on the exterior. 10,000 pieces of cut limestone were used for its construction. 3,400 pieces of glass were used during window construction

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/zfmj69/biotechnology_che) has announced the addition of the “Biotechnology, Chemical and Materials Engineering” report to their offering.

WHAT: The community is invited to attend the 9th Annual Celebration of Biotechnology on Thursday, May 10 from 9:30 a.m. until 1 p.m. on the RTI Biologics campus in Progress Corporate Park, Alachua, Fla

NEW YORK, NY–(Marketwire -04/23/12)- Mergers and Acquisitions have been a hot topic in in the Biotechnology Industry recently.

SIOUX FALLS, S.D.–(BUSINESS WIRE)– The South Dakota Biotechnology Association is expanding its annual poster session for researchers by incorporating the event into its annual summit. The poster session will focus on the following areas of research: energy, animal science, food and agriculture (including plant science) and human health (including medical devices).

April 23, 2012 – Scheduled for June 18-21, 2012 BIO International Convention will feature educational track devoted to Biotech Patenting and Tech Transfer to discuss legal and legislative developments and how they may impact biotech companies. Panels will cover recent developments in patentability, prior user rights and trade secrets, IP issues affecting biomarker diagnostics and personalized medicine, and impact America Invents Act has on missions and policies of universities and non-profit institutions. Biotechnology Industry Organization 1201 Maryland Ave., SW, Ste